Skip to main content
. 2021 Sep 16;16(2):222–235. doi: 10.1111/irv.12905

TABLE 1.

Factors associated with HRSV infection among children aged <5 years, hospitalized with severe respiratory illness, Edendale and Klerksdorp‐Tshepong hospitals, South Africa, 2012–2015

Characteristic HRSV positive n/N (%) HRSV negative n/N (%) Univariate odds ratio (95% CI) p value Multivariable adjusted odds ratio (95% CI) ≤ 5 years p value
Total 601/2509 (23.9) 1908/2509 (76.1)
Age
<3 months 229/601 (38.1) 360/1908 (18.9) 4.8 (3.5–6.7) <0.001 4.5 (3.0–6.9) <0.001
3–5 months 134/601 (22.3) 306/1908 (16.0) 3.3 (2.4–4.7) <0.001 3.4 (2.2–5.2) <0.001
6–11 months 106/601 (17.6) 404/1908 (21.2) 2.0 (1.4–2.8) <0.001 2.0 (1.3–3.1) 0.001
12–23 months 78/601 (13.0) 427/1908 (22.4) 1.4 (1.0–2.0) 0.083 1.6 (1.1–2.6) 0.024
24–59 months 54/601 (9.0) 411/1908 (21.5) Reference Reference
Female 256/600 (42.7) 844/1907 (44.3) 0.9 (0.8–1.1) 0.493
Year
2012 188/601 (31.3) 521/1908 (27.3) Reference
2013 165/601 (27.5) 590/1908 (30.9) 0.8 (0.6–0.9) 0.037
2014 133/601 (22.1) 401/1908 (21.0) 0.9 (0.7–1.2) 0.521
2015 115/601 (19.1) 396/1908 (20.8) 0.8 (0.6–1.1) 0.110
Clinical presentation and course
Fever ≥38°C 370/598 (61.9) 1219/1896 (64.3) 0.9 (0.7–1.1) 0.284 1.3 (1.0–1.7) 0.035
Cough 581/596 (97.5) 1615/1890 (85.4) 6.6 (3.9–11.2) <0.001 7.6 (4.2–13.7) <0.001
Supplemental oxygen needed 409/599 (68.3) 1008/1889 (53.4) 1.9 (1.5–2.3) <0.001 1.4 (1.1–1.8) 0.002
Prolonged hospitalization (≥5 days) 302/601 (50.2) 913/1908 (47.9) 1.1 (0.9–1.3) 0.305
In‐hospital death 4/597 (0.7) 29/1883 (1.54) 0.4 (0.1–1.2) 0.082
Admitted to ICU 24/598 (4.0) 80/1887 (4.2) 0.9 (0.6–1.5) 0.809 0.4 (0.2–0.8) 0.012
Tachypnea 335/595 (56.3) 879/1880 (46.8) 1.5 (1.2–1.8) <0.001
Stridor 121/595 (20.3) 324/1878 (17.3) 1.2 (0.9–1.5) 0.091
Underlying medical conditions
HIV infection 32/549 (5.8) 246/1756 (14.0) 0.4 (0.3–0.6) <0.001 0.4 (0.3–0.6) <0.001
Prematurity 68/600 (11.3) 257/1907 (13.5) 0.8 (0.6–1.1) 0.167
Heart disease 1/600 (0.2) 5/1906 (0.3) 0.6 (0.07–5.44) 0.663
Malnutrition 92/534 (17.2) 469/1746 (26.9) 0.6 (0.4–0.7) <0.001 0.5 (0.4–0.7) <0.001
Chronic lung disease 1/600 (0.2) 3/1905 (0.2) 1.1 (0.11–10.2) 0.961
Asthma 7/600 (1.2) 27/1906 (1.4) 0.8 (0.4–1.9) 0.639
Coinfection
Tuberculosis 6/150 (4) 24/559 (4.3) 0.9 (0.4–2.3) 0.873
Streptococcus pneumoniae 35/404 (8.7) 151/1348 (11.2) 0.8 (0.5–1.1) 0.138
Influenza A/B 10/601 (1.7) 130/1908 (6.8) 0.2 (0.1–0.4) <0.001 0.2 (0.1–0.4) <0.001
Rhinovirus 154/601 (25.6) 763/1908 (40.0) 0.5 (0.4–0.6) <0.001 0.4 (0.3–0.5) <0.001
Adenovirus 93/601 (15.5) 460/1908 (24.1) 0.6 (0.5–0.7) <0.001
Enterovirus 35/601 (5.8) 142/1908 (7.4) 0.8 (0.5–1.1) 0.168 0.6 (0.4–0.9)
Human metapneumovirus 5/601 (0.8) 115/1908 (6.0) 0.1 (0.05–0.3) <0.001 0.1 (0.04–0.3) <0.001
Parainfluenza virus types 1, 2, 3 10/601 (1.7) 168/1908 (8.8) 0.2 (0.1–0.3) <0.001 0.2 (0.1–0.5) 0.003

Note: Bold emphasizes statistically significant variables.

CI = confidence interval; ICU = intensive care unit; n/N = sample size/population size.